TRAW Latest Press Releases

-- May 27, 2026 --

Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks Globe Newswire 8:45 AM

-- May 15, 2026 --

Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results Globe Newswire 7:00 AM

-- May 8, 2026 --

Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections Globe Newswire 7:30 AM

-- April 15, 2026 --

Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights Globe Newswire 4:01 PM

Traws Pharma Announces Up to $60 Million Private Placement Financing Globe Newswire 8:15 AM

-- February 19, 2026 --

Traws Pharma Completes Analysis of Ratutrelvir Clinical Study in PAXLOVID-Eligible and Ineligible COVID-19 Patients and Provides Updates for Additional Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza Globe Newswire 7:30 AM

-- January 26, 2026 --

Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza Globe Newswire 8:30 AM

-- January 13, 2026 --

Traws Pharma Files Tivoxavir Marboxil Investigational New Drug (IND) Application for Influenza Therapy, and Provides Updated Results from the Ongoing Clinical Study of Ratutrelvir in PAXLOVID-Eligible and Ineligible COVID-19 Patients Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software